The Nutritional Intervention of Resveratrol Can Effectively Alleviate the Intestinal Inflammation Associated With Celiac Disease Induced by Wheat Gluten
Open Access
- 5 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 878186
Abstract
Background and Aims: Wheat gluten is a critical trigger for celiac disease, often causing inflammatory lesions and oxidative stress damage in the intestines of patients. In daily life, it is difficult for celiac disease patients to strictly avoid the dietary intake of gluten, which makes complementary preventive therapy particularly urgent. As such, we investigated the alleviating effects of resveratrol in vivo and in vitro models of celiac disease.Methods: We established in vivo and in vitro models of gluten protein-induced celiac disease. The intervention effect of resveratrol was defined well based on relevant indicators of inflammation, immunity and oxidative stress, and its possible involvement in signaling pathways and genes were also identified.Results: Resveratrol was effective in reducing intestinal oxidative stress and inflammatory damage induced by wheat gluten in both cell and mouse models for celiac disease. We identified correlations between the genes (Fgf15, Nr0b2, Aire and Ubd) and signaling pathways (PPAR, AMPK and FoxO) in which resveratrol performed critical roles.Conclusions: Resveratrol contributed to regulate development of autoimmunity through up-regulation of Aire and Ubd genes and promote nutrient absorption in intestine through down-regulation of Fgf15 and Nr0b2 genes, as well as played a role in regulating complex response system of oxidative stress, inflammatory response and immune response in intestine by activating PPAR, AMPK and FoxO signaling pathways, thus effectively alleviating the intestinal symptoms of celiac disease.Keywords
Funding Information
- International Science and Technology Cooperation Programme (2013DFG31380)
This publication has 65 references indexed in Scilit:
- Celiac Disease, Inflammation and Oxidative Damage: A Nutrigenetic ApproachNutrients, 2012
- The intestinal B-cell response in celiac diseaseFrontiers in Immunology, 2012
- Aire and T cell developmentCurrent Opinion in Immunology, 2011
- A genetic perspective on coeliac diseaseTrends in Molecular Medicine, 2010
- Peroxisome proliferator‐activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitisImmunology, 2010
- Resveratrol (Trans-3,5,4′-trihydroxystilbene) Induces Silent Mating Type Information Regulation-1 and Down-Regulates Nuclear Transcription Factor-κB Activation to Abrogate Dextran Sulfate Sodium-Induced ColitisThe Journal of Pharmacology and Experimental Therapeutics, 2010
- FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and InflammationGastroenterology, 2009
- Prohibitin Is a Novel Regulator of Antioxidant Response That Attenuates Colonic Inflammation in MiceGastroenterology, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosisProceedings of the National Academy of Sciences, 2008